• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THE HONEY POT COMPANY LLC. HONEY POT COMPWNY HERBAL OVERNIGHT HEAVY FLOW PADS WITH WINGS, ORGANIC; PADS, MENSTRUAL, SCENTED-DEODORIZED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THE HONEY POT COMPANY LLC. HONEY POT COMPWNY HERBAL OVERNIGHT HEAVY FLOW PADS WITH WINGS, ORGANIC; PADS, MENSTRUAL, SCENTED-DEODORIZED Back to Search Results
Health Effect - Clinical Codes Foreign Body Reaction (1868); Burning Sensation (2146); Numbness (2415)
Date of Event 01/15/2025
Type of Reportable Event Serious Injury
Event or Problem Description
Purchased the cooling herbal version of the honey pot overnight pads since the non herbal wasn't available.Within minutes experienced numb burning cold sensation.Wasn't "cooling" or pleasant at all.Even after a full ten minutes of rinsing vaginal area, burning sensation remained.Took over an hour for burning numb feeling to fully dissipate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HONEY POT COMPWNY HERBAL OVERNIGHT HEAVY FLOW PADS WITH WINGS, ORGANIC
Common Device Name
PADS, MENSTRUAL, SCENTED-DEODORIZED
Manufacturer (Section D)
THE HONEY POT COMPANY LLC.
MDR Report Key21209970
Report NumberMW5165061
Device Sequence Number8256394
Product Code NRC
Combination Product (Y/N)N
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Unknown
Type of Report Initial
Report Date (Section B) 01/15/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date01/22/2025
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexFemale
-
-